Literature DB >> 7633976

Fibrin sealant reduces suture line bleeding during carotid endarterectomy: a randomised trial.

A A Milne1, W G Murphy, S J Reading, C V Ruckley.   

Abstract

OBJECTIVES: To determine whether topical fibrin sealant reduced suture line bleeding during carotid endarterectomy with polytetrafluoroethylene (PTFE) patch closure.
DESIGN: Prospective randomised non-blinded control trial.
SETTING: Regional vascular surgery unit. MATERIALS: Seventeen patients undergoing carotid endarterectomy were randomised either to receive fibrin sealant as a topical haemostatic agent at the arteriotomy suture line or to act as control. OUTCOME MEASURES: Time taken to achieve haemostasis at the suture line. Intraoperative blood loss. Total operative time.
RESULTS: The median time to achieve haemostasis was 5.5 min (range 4-31 min) in the treatment group and 19 min (range 10-47 min) in the control group. This difference was statistically significant p < 0.005 by Mann-Whitney test. There was no statistical difference in total operative time. Operative blood loss was lower in the treatment group (median 420ml, range 300-500ml) than in the control group (median 550ml, range 350-1200ml) but this difference was not statistically significant. One patient in the control group suffered a perioperative thrombo-embolic event.
CONCLUSION: Fibrin sealant is an effective topical haemostatic agent for arteriotomy suture lines involving PTFE material.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633976     DOI: 10.1016/s1078-5884(05)80203-5

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  Experimental study on effective application of fibrin glue.

Authors:  Hajime Kin; Takayuki Nakajima; Hitoshi Okabayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-15

2.  Analysis of the hemostatic potential of modern topical sealants on arterial and venous anastomoses: an experimental porcine study.

Authors:  Hamidreza Fonouni; Arash Kashfi; Ali Majlesara; Oliver Stahlheber; Lukas Konstantinidis; Thomas W Kraus; Arianeb Mehrabi; Hani Oweira
Journal:  J Mater Sci Mater Med       Date:  2017-07-28       Impact factor: 3.896

3.  Stability of human thrombin produced from 11 ml of plasma using the thrombin processing device.

Authors:  Vijay Kumar; Trista Madsen; Haihong Zhu; Elisabeth Semple
Journal:  J Extra Corpor Technol       Date:  2005-12

Review 4.  Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.

Authors:  P A Carless; D A Henry; D M Anthony
Journal:  Cochrane Database Syst Rev       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.